The glutamate/neutral amino acid transporter family SLC1: molecular, physiological and pharmacological aspects
about
sameAs
Metabolic activation-related CD147-CD98 complexThe role of glutamate signaling in the pathogenesis and treatment of obsessive-compulsive disorderUsing glutamate homeostasis as a target for treating addictive disordersExpression profiling of the solute carrier gene family in the mouse brainThinking outside the cleft to understand synaptic activity: contribution of the cystine-glutamate antiporter (System xc-) to normal and pathological glutamatergic signalingOligonucleotide microarray analysis of differential transporter regulation in the regenerating rat liverA novel transporter of SLC22 family specifically transports prostaglandins and co-localizes with 15-hydroxyprostaglandin dehydrogenase in renal proximal tubulesEvaluation of cell-free protein synthesis for the crystallization of membrane proteins--a case study on a member of the glutamate transporter family from Staphylothermus marinus.The Concise Guide to PHARMACOLOGY 2013/14: transporters.Broad integration of expression maps and co-expression networks compassing novel gene functions in the brain.Global gene expression in endometrium of high and low fertility heifers during the mid-luteal phase of the estrous cycle.Panorganismal metabolic response modeling of an experimental Echinostoma caproni infection in the mousePhylogenetic analysis of the vertebrate excitatory/neutral amino acid transporter (SLC1/EAAT) family reveals lineage specific subfamiliesH+-coupled nutrient, micronutrient and drug transporters in the mammalian small intestineWidespread microRNA dysregulation in multiple system atrophy - disease-related alteration in miR-96.Glutamate transporters and the excitotoxic path to motor neuron degeneration in amyotrophic lateral sclerosis.Amino Acid transport mechanisms in mouse oocytes during growth and meiotic maturation.Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression.System xc⁻ cystine/glutamate antiporter: an update on molecular pharmacology and roles within the CNS.SNAT2 silencing prevents the osmotic induction of transport system A and hinders cell recovery from hypertonic stress.Regulation of renal amino acid transporters during metabolic acidosis.Tumor necrosis factor-α suppresses the protein fractional synthesis rate of the small intestine stimulated by glutamine in rats.Investigation of the association between SLC1A3 gene polymorphisms and normal tension glaucomaComprehensive family-based association study of the glutamate transporter gene SLC1A1 in obsessive-compulsive disorder.New views of glutamate transporter structure and function: advances and challenges.Novel dicarboxylate selectivity in an insect glutamate transporter homolog.The blood-brain barrier and glutamate.Placental accommodations for transport and metabolism during intra-uterine crowding in pigsThe fate of bacterial cocaine esterase (CocE): an in vivo study of CocE-mediated cocaine hydrolysis, CocE pharmacokinetics, and CocE elimination.Reduction of EEG theta power and changes in motor activity in rats treated with ceftriaxone.OCDB: a database collecting genes, miRNAs and drugs for obsessive-compulsive disorderGenome-wide association between single nucleotide polymorphisms with beef fatty acid profile in Nellore cattle using the single step procedure.Transporters for L-glutamate: an update on their molecular pharmacology and pathological involvement.Molecular basis of essential amino acid transport from studies of insect nutrient amino acid transporters of the SLC6 family (NAT-SLC6)Pre-ischemic treadmill training for prevention of ischemic brain injury via regulation of glutamate and its transporter GLT-1.The role of the neutral amino acid transporter SNAT2 in cell volume regulation.Intracellular mGluR5 plays a critical role in neuropathic painGlutamate transporters in brain ischemia: to modulate or not?The glycine deportation system and its pharmacological consequences.An SLC6 transporter of the novel B(0,)- system aids in absorption and detection of nutrient amino acids in Caenorhabditis elegans
P2860
Q24539137-822ACDB0-58EE-4961-8666-BBCAD266BEFAQ24605193-236E0402-F18E-4393-8032-F6DC3B63D1B7Q24619198-E7220420-8460-4F97-A7D1-EB5FF5CE5F5DQ24655257-EF3B1AA5-3FE2-4CF0-939C-EC73F90EA74FQ26864995-2872670A-CB1B-4815-9BE3-BF3D40807251Q28565904-07A1743C-C0A9-4E7D-B56E-B1370B1CECDDQ28593864-E0DDD18C-D3A9-4829-A7F8-E34A52C9217BQ30425362-BD7D4D9C-468D-4AE3-9DC9-6DDE9B0341F3Q30486743-B80E211D-2085-4948-8595-4F7B57899E40Q30597210-1DED6CD6-0C10-4C9A-B579-6AF6A63E2A8FQ31154677-B9D4BD63-2E48-454D-9A8B-27C124881E5BQ33458697-418BDEB7-A0FD-438C-8B27-FFCAA72273D0Q33568182-08360BF9-A5AA-4E48-BF96-46544A71C5F5Q33578118-13906C92-87EF-4B21-90E7-B46AC15B5A82Q33738316-F01F6CBE-6D4D-4B67-AE77-ED47FD3AF7D9Q33742729-D978CE58-6DF5-4D4C-A06B-8FA43F094B2FQ33749375-1B903829-6EC4-49E1-B583-A1F8DF1A6AB2Q34084102-230F82B7-FEB1-4AB7-AFD6-0D6C26265159Q34184493-AB6A9A63-9FFA-4432-9948-44F564CC96EBQ34422115-6FEBF425-953F-405E-82FE-F8D7832A1FC7Q34652907-890BE611-DF80-4BF7-B755-4C5E300BBF8EQ34795654-B3DCDAF0-ABAC-4809-9B7C-1DBD431F1889Q34848918-EE325450-8AED-4278-94E9-333524AE951DQ34861283-86CE3D43-8FEF-4B29-ADE1-1EA5112A0674Q34865910-67E486ED-6A3A-4443-8243-5D588D8A4BEEQ34948160-D158C3D2-A8D4-4C04-8C14-37C8373D71C8Q35104343-D144FD83-32CB-44C4-825B-08727D028CAEQ35559131-7760ACE4-8259-46D7-BE30-1B8C8D03F53AQ35650695-DFCE5098-9C23-4A18-8C14-1FAA3E0AF06AQ35862972-254CA425-07F4-43C3-BEA8-51647D042321Q35901896-065EF6D3-CBDA-4C38-98EE-C4A7B7E3200EQ35951589-8BEF4E80-F2A4-4FAD-9176-2AC0357C735EQ36052481-DB522FED-9C77-4091-8E7C-05FFEEA6C8D8Q36096856-0FFFCDE8-4AFB-4EDF-9EA0-1A3580804FD8Q36202246-31B5CFDD-963B-4AA0-B813-123107227CA9Q36492540-57FB2059-B7B2-492A-B439-B6110E9F1788Q36549290-CE5BF850-AC8F-4D03-B002-04D4DB21837BQ36745208-6FD982DB-7CD5-4E62-B1F9-E6CD147E95CAQ36880287-EE777BBD-243D-4FE1-A438-86FADB2B557CQ37020958-AA697DEB-6D30-4DF1-B7F4-4845494DB403
P2860
The glutamate/neutral amino acid transporter family SLC1: molecular, physiological and pharmacological aspects
description
2004 nî lūn-bûn
@nan
2004 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
The glutamate/neutral amino ac ...... al and pharmacological aspects
@ast
The glutamate/neutral amino ac ...... al and pharmacological aspects
@en
The glutamate/neutral amino ac ...... al and pharmacological aspects
@nl
type
label
The glutamate/neutral amino ac ...... al and pharmacological aspects
@ast
The glutamate/neutral amino ac ...... al and pharmacological aspects
@en
The glutamate/neutral amino ac ...... al and pharmacological aspects
@nl
prefLabel
The glutamate/neutral amino ac ...... al and pharmacological aspects
@ast
The glutamate/neutral amino ac ...... al and pharmacological aspects
@en
The glutamate/neutral amino ac ...... al and pharmacological aspects
@nl
P1433
P1476
The glutamate/neutral amino ac ...... al and pharmacological aspects
@en
P2093
Matthias A Hediger
Yoshikatsu Kanai
P2888
P304
P356
10.1007/S00424-003-1146-4
P407
P577
2004-02-01T00:00:00Z
P6179
1028136264